Global Continuous Glucose Monitoring Systems (CGMS) Market is expected to reach $3.6 billion by 2022

 

Contact Information
KBV Research
Sector – 1, Vaishali – 201010, Delhi NCR, Ghaziabad
Ghaziabad
UP - 201010
India
6466616066
shivanisingh@kbvresearch.com
 
According to a new report, “Global Continuous Glucose Monitoring Systems (CGMS) Market (2016-2022)”, published by KBV Research, the Global Continuous Glucose Monitoring Systems Market is expected to reach $3.6 billion by 2022, growing at a CAGR of 28.2% during 2016 -2022.The North America market dominated the Global Continuous Glucose Monitoring Systems Market in 2015, and would grow at a CAGR of 28.1% during the forecast period. However, Asia-Pacific market is expected to grow at CAGR of 32% during 2016-2022.

The Sensors market contributed the larger revenue share to the Global Continuous Glucose Monitoring Systems Market in 2015, and is expected to grow at a CAGR of 31% during the forecast period. The Transmitters & Receivers market is expected attain a market size of $703 million by 2022.

The Diagnostic centers/clinics market registered the largest revenue share in the Global Continuous Glucose Monitoring Systems Market in 2015, and would reach a market size of $1.6 billion by 2022, growing at a CAGR of 27.4% during the forecast period. The Home Healthcare market is expected to grow at CAGR of 42% during 2016-2022.

The report highlights the adoption of Continuous Glucose Monitoring Systems, globally.Based on the Component, the Global Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The geographiesincluded in the report are North America, Europe, Asia Pacific and LAMEA (Latin America, Middle East and Africa).

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Full report: http://kbvresearch.com/global-continuous-glucose-monitoring-systems-market/

Research Scope
The market is segmented based on Component, End User and Geography.

Global Continuous Glucose Monitoring Systems Market, by Component
Hardware
Software
Services
Global Continuous Glucose Monitoring Systems Market, by End User
Displays Terminals
Interface Software
Industrial PCs
Other Controllers
Global Continuous Glucose Monitoring Systems Market, by Geography
North America
U.S
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Company Profiles
Roche Diagnostics
Abbott Laboratories
Dexcom Inc.
Novo Nordisk
Ypsomed AG
GlySens Incorporated
Medtronic Plc and
Johnson & Johnson

Related Reports-
Europe Continuous Glucose Monitoring Systems Market
Asia Pacific Continuous Glucose Monitoring Systems Market
North America Continuous Glucose Monitoring Systems Market
Lamea Continuous Glucose Monitoring Systems Market

Continuous Glucose Monitoring Systems Market

 

If you have any questions regarding information in this press release, please contact the person listed in the Contact / Company information box of this page. Please do not attempt to contact Market Press Release. We will be unable to assist you with any information regarding this release. Market Press Release disclaims any content contained in this press release.